Evaluation of percutaneous intratumoral injection of p53 gene in the treatment of inoperable hepatocellular carcinoma as compared to alcohol injection
Egyptian Journal of Surgery [The]. 1999; 18 (3): 302-306
in English
| IMEMR
| ID: emr-118391
ABSTRACT
P53 is a tumour suppressor gene on chromosome 17 P. Alterations [deletion or mutation] within the coding sequences of the gene are among the most frequent genetic changes detected in human neoplasm. The use of gene therapy in some tumours is a new trend nowadays which carries many hopes for the future treatment of these tumors. This modality of treatment utilizes transfer vectors [plasmid, virus,] for delivering certain genes into malignant cells to induce tumour suppression. Injection of P53 intratumoral [I.T] in Hepatocellular Carcinoma [H.C.C.] is an example of this therapy. The aim of this study is to compare the effect of intratumoral injection of P 53 to that achieved with alcohol injection in cases of H.C.C. In a prospective study, eleven consecutive patients, diagnosed as H.C.C., were subjected to I.T injection of alcohol [Group I] and another eleven patients were subjected to I.T P 53 injection [Group II]. The results show that alcohol injection has superior results in treating H.C.C. over P 53 injection
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Comparative Study
/
Genetic Therapy
/
Genes, p53
/
Treatment Outcome
/
Ethanol
/
Intubation, Intratracheal
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Egypt. J. Surg.
Year:
1999
Similar
MEDLINE
...
LILACS
LIS